CRSmultiorgan failureTocilizumabuniversity hospitalCAR-T cell therapies
…s from January 2018 to July 2025 were retrospectively analysed. CRS episodes were graded using ASTCT criteria; therapeutic treatmen…
12articles mentioning diseases
48disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: CRS ×
CRS
This disease is selected. Its supporting articles are shown below.
Articles mentioning CRS
12 articles · page 1 of 1Chronic rhinosinusitisCRSwNPCRSsevere asthmaCRSsNP
…Introduction and Objectives Chronic rhinosinusitis (CRS), with nasal polyps (CRSwNP) or without NP (CRSsNP), is co…
CRSOCrecurrent advanced OCsarilumabubamatamab
…4.Conclusions A single sarilumab dose before ubamatamab reduced CRS incidence and severity. Pharmacokinetic and pharmacodynamic fin…
haematologic malignanciesCRScytokine release syndromemultiorgan failureTocilizumabuniversity hospitalcorticosteroidsCAR-T cell therapy
…CAR-T cell therapy is a major breakthrough in the management of haematologic malignancies, but its use is associated with severe adverse events requiring…
Cytokine release syndromeCRSOKT3TransCure bioServicesimmune checkpoint inhibitorsT cell engagers
…Background Cytokine release syndrome (CRS) is a serious immune-related toxicity frequently associate…
chronic rhinosinusitisCRSclarithromycinendoscopic sinus surgery
…effective whereas clarithromycin was no better than placebo for chronic rhinosinusitis (CRS)—and to identify barriers and facilitators to the implemen…
Systemic sclerosis (SSc)interstitial lung diseaseSSc heart diseaseCRSteclistamab
…Introduction Systemic sclerosis (SSc) is a severe autoimmune disease in which disease-specific autoan…
pancreatic cancersolid tumorsgraft-versus-host disease (GvHD)CRSGvHDcytokine release syndromePCcancer immunotherapy
…receptors (CARs), remains underexplored in solid tumors such as pancreatic cancer (PC), largely due to their low abundance in peripheral blood an…
asthmachronic rhinosinusitisCRSFeNO
… is novel in exploring functional gene profiling in relation to asthma and FeNO.…
dcSSccytokine release syndrome (CRS)diffuse cutaneous systemic sclerosis (dcSSc)CRStocilizumabeculizumabATGDutch university hospitalsAmerican Society for Transplantation and Cellular Therapy
…the median disease duration was 13 months (IQR 7-23). 87.1% had dcSSc and 12.9% had limited cutaneous SSc. At baseline the mean perce…
multiple myelomaDLBCLacute lymphoblastic leukaemiadiffuse large B-cell lymphomaICANSMMALLcytokine release syndromeimmune effector cell-associated neurotoxicity syndrome (ICANS)
…= 53, 76%), acute lymphoblastic leukaemia (ALL, n = 6, 9%), and multiple myeloma (MM, n = 6, 9%). CAR-T products: axicabtagene ciloleucel (n = 3…